SERP1
Basic information
Region (hg38): 3:150541998-150603228
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SERP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 2 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 2 | 0 | 0 |
Variants in SERP1
This is a list of pathogenic ClinVar variants found in the SERP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-150544470-C-A | not specified | Uncertain significance (Jun 04, 2024) | ||
3-150545769-G-C | not specified | Uncertain significance (Feb 27, 2024) | ||
3-150546114-G-A | not specified | Uncertain significance (Mar 13, 2023) | ||
3-150546806-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
3-150546818-C-G | not specified | Uncertain significance (Nov 21, 2022) | ||
3-150552359-G-A | not specified | Uncertain significance (May 05, 2023) | ||
3-150558461-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
3-150562603-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
3-150563565-A-G | not specified | Uncertain significance (Oct 12, 2022) | ||
3-150563596-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
3-150564299-G-T | not specified | Uncertain significance (Apr 12, 2022) | ||
3-150564312-T-G | not specified | Uncertain significance (May 25, 2022) | ||
3-150564367-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
3-150567762-A-C | not specified | Uncertain significance (Mar 29, 2022) | ||
3-150568002-G-T | Dystonia 33 | Uncertain significance (Sep 22, 2024) | ||
3-150568006-C-A | not specified | Uncertain significance (Jun 04, 2024) | ||
3-150568193-A-G | not specified | Uncertain significance (Mar 23, 2023) | ||
3-150568213-C-A | not specified | Uncertain significance (Aug 26, 2022) | ||
3-150571970-C-A | EIF2A-related disorder | Likely benign (Mar 10, 2023) | ||
3-150572021-A-G | not specified | Uncertain significance (Jan 05, 2022) | ||
3-150572054-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
3-150572075-T-C | not specified | Uncertain significance (Oct 14, 2021) | ||
3-150572093-C-G | not specified | Uncertain significance (Feb 21, 2024) | ||
3-150572129-T-C | not specified | Uncertain significance (Dec 15, 2022) | ||
3-150572246-C-T | not specified | Uncertain significance (May 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SERP1 | protein_coding | protein_coding | ENST00000479209 | 3 | 61235 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.265 | 0.645 | 125742 | 0 | 2 | 125744 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.900 | 22 | 37.5 | 0.586 | 0.00000161 | 429 |
Missense in Polyphen | 9 | 22.255 | 0.4044 | 260 | ||
Synonymous | -0.571 | 16 | 13.3 | 1.20 | 6.09e-7 | 113 |
Loss of Function | 1.26 | 1 | 3.58 | 0.279 | 1.52e-7 | 43 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000340 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Interacts with target proteins during their translocation into the lumen of the endoplasmic reticulum. Protects unfolded target proteins against degradation during ER stress. May facilitate glycosylation of target proteins after termination of ER stress. May modulate the use of N-glycosylation sites on target proteins (By similarity). {ECO:0000250}.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;XBP1(S) activates chaperone genes;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- loftool
- 0.577
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.25
Haploinsufficiency Scores
- pHI
- 0.226
- hipred
- Y
- hipred_score
- 0.501
- ghis
- 0.565
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.901
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Low | Low | Low |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Serp1
- Phenotype
- skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- skeletal system development;glucose metabolic process;cellular protein modification process;protein glycosylation;plasma membrane organization;post-embryonic development;multicellular organism aging;protein transport;endoplasmic reticulum unfolded protein response;positive regulation of insulin secretion;IRE1-mediated unfolded protein response;positive regulation of translation;positive regulation of organ growth;muscle organ morphogenesis;positive regulation of growth hormone secretion
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;ribosome;cytoplasmic microtubule;integral component of membrane
- Molecular function
- protein binding